This site uses cookies. By using this site you agree to receiving cookies. View Policy.
/https://files-crowdcube-com.s3.amazonaws.com/opportunity_images/24583/201903/5200b42dd17cddf94841d6c67192e48e.jpg "Belluscura plc")
/https://files-crowdcube-com.s3.amazonaws.com/files/pitch_pics/original/201808/c75467a42f1d420783ee73ab9616c0a6 "Belluscura plc")
Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.
Back to company profile
Financial data drawn from last filed accounts don't necessarily reflect current trading activity. Financials provided by Company Check.
Accounts
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| Turnover | £32.73k | £285.92k | £194.39k |
| Cash | £973.17k | £146.52k | £421.35k |
| Increase in Cash | £1.8m | £-867.48k | £286.35k |
Profit & Loss
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| Audit Fees | £15.69k | £16.47k | £27.48k |
| Cost of Sales | £25.33k | £296.74k | £200.18k |
| Depreciation | £5.01k | £5.05k | £7.53k |
| Directors Emoluments | £188.15k | £448.82k | £308.49k |
| Dividends | - | - | - |
| Export | - | - | - |
| Gross Profit | £7.4k | £-10.82k | £-5.79k |
| Interest Payments | £0 | £0 | £0 |
| Operating Profit | £-743.1k | £-2.24m | £-1.17m |
| Pretax Profit | £-743.1k | £-2.24m | £-1.17m |
| Profit after Tax | £-743.1k | £-2.24m | £-1.17m |
| Retained Profit | £-743.1k | £-2.24m | £-1.17m |
| Taxation | £0 | £0 | £0 |
| Turnover | £32.73k | £285.92k | £194.39k |
| Wages & Salaries | £307.73k | £766.76k | £614.49k |
Balance Sheet
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| Intangible Assets | £136.21k | £126.59k | £0 |
| Bank Loans & Overdrafts | £0 | £0 | £0 |
| Cash | £973.17k | £146.52k | £421.35k |
| Miscellaneous Current Assets | £0 | £0 | £0 |
| Miscellaneous Current Liabilities | £45.85k | £260.44k | £81.74k |
| Other Debtors | £66.57k | £56.12k | £11.13k |
| Other Long Term Finance | £0 | £0 | £0 |
| Other Short Term Finance | £137k | £169.33k | £0 |
| Stock | £3.43k | £62.76k | £101.4k |
| Tangible Accounts | £35.25k | £1.04m | £1.46m |
| Total Current Assets | £1.06m | £326.04k | £559.25k |
| Total Current Liabilities | £313.9k | £1.08m | £200.09k |
| Total Fixed Assets | £171.46k | £1.17m | £1.46m |
| Total Long Term Finance | £0 | £0 | £0 |
| Trade Creditors | £131.05k | £646.88k | £118.35k |
| Trade Debtors | £12.38k | £60.62k | £25.37k |
Capital & Reserves
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| Profit & Loss Account Reserve | £-743.1k | £141.99k | £-1.03m |
| Called up share capital | £91.6k | £127.44k | £361.07k |
| Revaluation Reserve | £0 | £0 | £0 |
| Shareholder Funds | £913.11k | £420.6k | £1.82m |
| Sundry Reserves | £1.56m | £151.18k | £2.49m |
Cash
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| Increase in Cash | £1.8m | £-867.48k | £286.35k |
| Net Cash Flow Before Financing | £-15.83k | £722.36k | £-2.52m |
| Net Cash Flow From Financing | £1.81m | £-1.59m | £2.81m |
| Net Cash Flow From Operations | £-545.75k | £-1.41m | £-1.89m |
Other Financials
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| Net Assets | £913.11k | £420.6k | £1.82m |
| Net Worth | £776.9k | £294.01k | £1.82m |
| Total Assets | £1.23m | £1.5m | £2.02m |
| Total Liabilities | £313.9k | £1.08m | £200.09k |
| Working Capital | £741.65k | £-750.61k | £359.17k |
Ratios
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| Creditor Days | 1.46k% | 902.73% | 221.6% |
| Current Debt Ratio | 0.34% | 2.55% | 0.1% |
| Current Ratio | 3.36% | 0.3% | 2.8% |
| Debtor Days | 137.74% | 84.6% | 47.51% |
| Equity In Percentage | 83.7% | 30.7% | 90.1% |
| Gearing | 0% | 0% | 0% |
| Liquidity Ratio Or Acid Test | 3.35% | 0.24% | 2.28% |
| Pre Tax Profit Margin | -2.27k% | -783.34% | -601.98% |
| Return On Capital Employed | -81.38% | -532.49% | -64.32% |
| Return On Net Assets Employed | -81.38% | -532.49% | -64.32% |
| Return On Total Assets Employed | -60.56% | -149.58% | -57.95% |
| Sales Or Net Working Capital | 0% | 0% | 0% |
| Stock Turnover Ratio | 10.46% | 21.95% | 52.16% |
| Total Debt Ratio | 0.34% | 2.55% | 0.1% |
